Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy
Treatment and vaccine efficacy in clinical trials are often reported in the media and medical journals as the relative risk reduction. The present article explains why the relative risk reduction is a misinformative measure that promotes disinformation when reporting efficacy in clinical research st...
Main Author: | Ronald B. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Dialogues in Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772653322000740 |
Similar Items
-
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
by: Ronald B. Brown
Published: (2021-02-01) -
What are relative risk, number needed to treat and odds ratio?
by: Prasad Kameshwar
Published: (2007-01-01) -
Number needed to treat
by: Amitabh Biswas
Published: (2017-01-01) -
Trends in varicella epidemiology before and after the implementation of universal one-dose varicella vaccination
by: Shih-Wei Lai
Published: (2019-11-01) -
Reduction in number to treat versus number needed to treat
by: Chenyang Zhang, et al.
Published: (2021-03-01)